Review on In Vivo Profiling of Drug Metabolites with Lc-Ms/Ms in the Past Decade

References

• Nalbantoglu S . Metabolomics: Basic principles and strategies. Mol. Med.IntechOpenDOI: 10.5772/intechopen.88563 (2019). https://www.intechopen.com/chapters/68486
   Google Scholar
• Bowen BP , NorthenTR. Dealing with the unknown: metabolomics and metabolite atlases. J. Am. Soc. Mass Spectrom.21(9), 1471–1476 (2010).
   PubMed Web of Science ®Google Scholar
• Kwak M , KangK, WangY. Methods of metabolite identification using MS/MS data. J. Comput. Inf. Syst.1–7 https://doi.org/10.1080/08874417.2019.1681328 (2019).
   Google Scholar
• Pauling L , RobinsonAB, TeranishiR, CaryP. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc. Natl Acad. Sci. USA68(10), 2374–2376 (1971).
   PubMed Web of Science ®Google Scholar
• Horning EC , HorningM-G. Metabolic profiles: gas-phase methods for analysis of metabolites. Clin. Chem.17(8), 802–809 (1971).
   PubMed Web of Science ®Google Scholar
• Oliver SG , WinsonMK, KellDB, BaganzF. Systematic functional analysis of the yeast genome. Trends Biotechnol.16(9), 373–378 (1998).
   PubMed Web of Science ®Google Scholar
• Zhang Z , ZhuM, TangW. Metabolite identification and profiling in drug design: current practice and future directions. Curr. Pharm. Des.15(19), 2220–2235 (2009).
   PubMed Web of Science ®Google Scholar
• Prasad B , GargA, TakwaniH, SinghS. Metabolite identification by liquid chromatography-mass spectrometry. Trends Anal. Chem.30(2), 360–387 (2011).
   Web of Science ®Google Scholar
• Xiao JF , ZhouB, RessomHW. Metabolite identification and quantitation in LC-MS/MS-based metabolomics. Trends Anal. Chem.32, 1–14 (2012).
   PubMed Web of Science ®Google Scholar
• Roessner U , BowneJ. What is metabolomics all about?BioTechniques46(5), 363–365 (2009).
   PubMed Web of Science ®Google Scholar
• Want EJ , CravattBF, SiuzdakG. The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem6(11), 1941–1951 (2005).
   PubMed Web of Science ®Google Scholar
• Muhamad N , Na-BangchangK. Metabolite profiling in anticancer drug development: a systematic review. Drug Des. Devel. Ther.14, 1401 (2020).
   PubMed Web of Science ®Google Scholar
• Clarke NJ , RindgenD, KorfmacherWA, CoxKA. Peer reviewed: systematic LC/MS metabolite identification in drug discovery. Anal. Chem.73(15), 430 A–439 A (2001).
   Web of Science ®Google Scholar
• Paul W , SteinwedelH. A new mass spectrometer without a magnetic field. Zeitschrift fuer Naturforschung (West Germany) Divided into Z. Nautrforsch., A, and Z. Naturforsch., B: Anorg. Chem., Org. Chem., Biochem., Biophys.8 (1953).
   Google Scholar
• Perchalski RJ , YostRA, WilderB. Structural elucidation of drug metabolites by triple-quadrupole mass spectrometry. Anal. Chem.54(9), 1466–1471 (1982).
   Web of Science ®Google Scholar
• Lee MS , YostRA. Rapid identification of drug metabolites with tandem mass spectrometry. Biomed. Environ. Mass Spectrom.15(4), 193–204 (1988).
   PubMedGoogle Scholar
• Bateman KP , Castro-PerezJ, WronaMet al. MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun. Mass Spectrom.21(9), 1485–1496 (2007).
   PubMed Web of Science ®Google Scholar
• Gajula SNR , NadimpalliN, SontiR. Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug Metab. Rev. ( just-accepted), 1–47 (2021).
   Google Scholar
• Lu D , ZhangS, WangDet al. Identification of flurochloridone metabolites in rat urine using liquid chromatography/high resolution mass spectrometry. J. Chromatogr. A1445, 80–92 (2016).
   PubMed Web of Science ®Google Scholar
• Lei Z , HuhmanDV, SumnerLW. Mass spectrometry strategies in metabolomics. J. Biol. Chem.286(29), 25435–25442 (2011).
   PubMed Web of Science ®Google Scholar
• Theodoridis GA , GikaHG, WantEJ, WilsonID. Liquid chromatography–mass spectrometry based global metabolite profiling: a review. Anal. Chim. Acta711, 7–16 (2012).
   PubMed Web of Science ®Google Scholar
• Beckonert O , KeunHC, EbbelsTMet al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc.2(11), 2692–2703 (2007).
   PubMed Web of Science ®Google Scholar
• Dunn WB , EllisDI. Metabolomics: current analytical platforms and methodologies. Trends Anal. Chem.24(4), 285–294 (2005).
   Web of Science ®Google Scholar
• Dunn WB , BroadhurstD, BegleyPet al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc.6(7), 1060–1083 (2011).
   PubMed Web of Science ®Google Scholar
• Vuckovic D . Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry. Anal. Bioanal. Chem.403(6), 1523–1548 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang Q-H , ZhouL-D, ChenH, WangC-Z, XiaZ-N, YuanC-S. Solid-phase microextraction technology for in vitro and in vivo metabolite analysis. Trends Anal. Chem.80, 57–65 (2016).
   PubMed Web of Science ®Google Scholar
• Navitha Reddy G , DilipZagade A, SenguptaP. Current direction and advances in analytical sample extraction techniques for drugs with special emphasis on bioanalysis. Bioanalysis11(04), 313–332 (2019).
   PubMedGoogle Scholar
• Gao D , WangD-D, ZhangQet al. In vivo selective capture and rapid identification of luteolin and its metabolites in rat livers by molecularly imprinted solid-phase microextraction. J. Agric. Food Chem.65(6), 1158–1166 (2017).
   PubMed Web of Science ®Google Scholar
• Simões RA , BonatoPS, MirnaghiFS, BojkoB, PawliszynJ. Bioanalytical method for in vitro metabolism study of repaglinide using 96-blade thin-film solid-phase microextraction and LC–MS/MS. Bioanalysis7(1), 65–77 (2015).
   PubMed Web of Science ®Google Scholar
• Wang C , LiP, LianAet al. Blood volatile compounds as biomarkers for colorectal cancer. Cancer Biol. Ther.15(2), 200–206 (2014).
   PubMed Web of Science ®Google Scholar
• Wang D-D , GaoD, HuangY-K, XuW-J, XiaZ-N. Preparation of restricted access molecularly imprinted polymers based fiber for selective solid-phase microextraction of hesperetin and its metabolites in vivo. Talanta202, 392–401 (2019).
   PubMed Web of Science ®Google Scholar
• Jager NG , RosingH, SchellensJH, BeijnenJH. Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review. Bioanalysis6(18), 2481–2514 (2014).
   PubMed Web of Science ®Google Scholar
• Schänzer W , OpfermannG, DonikeM. Metabolism of stanozolol: identification and synthesis of urinary metabolites. J. Steroid Biochem.36(1–2), 153–174 (1990).
   PubMedGoogle Scholar
• Thevis M , FußhöllerG, GeyerHet al. Detection of stanozolol and its major metabolites in human urine by liquid chromatography-tandem mass spectrometry. Chromatographia64(7), 441–446 (2006).
   Web of Science ®Google Scholar
• Engskog MK , HaglöfJ, ArvidssonT, PetterssonC. LC–MS based global metabolite profiling: the necessity of high data quality. Metabolomics12(7), 114 (2016).
   Web of Science ®Google Scholar
• Bruce SJ , TavazziI, ParisodVR, RezziS, KochharS, GuyPA. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal. Chem.81(9), 3285–3296 (2009).
   PubMed Web of Science ®Google Scholar
• León Z , García-CañaverasJC, DonatoMT, LahozA. Mammalian cell metabolomics: experimental design and sample preparation. Electrophoresis34(19), 2762–2775 (2013).
   PubMed Web of Science ®Google Scholar
• Michopoulos F , LaiL, GikaH, TheodoridisG, WilsonI. UPLC-MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. J. Proteome Res.8(4), 2114–2121 (2009).
   PubMed Web of Science ®Google Scholar
• Pereira H , MartinJ-F, JolyC, SébédioJ-L, Pujos-GuillotE. Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics6(2), 207–218 (2010).
   Web of Science ®Google Scholar
• Rico E , GonzálezO, BlancoME, AlonsoRM. Evaluation of human plasma sample preparation protocols for untargeted metabolic profiles analyzed by UHPLC-ESI-TOF-MS. Anal. Bioanal. Chem.406(29), 7641–7652 (2014).
   PubMed Web of Science ®Google Scholar
• Sarafian MH , GaudinM, LewisMRet al. Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography–mass spectrometry. Anal. Chem.86(12), 5766–5774 (2014).
   PubMed Web of Science ®Google Scholar
• Tulipani S , LlorachR, Urpi-SardaM, Andres-LacuevaC. Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: when less is more. Anal. Chem.85(1), 341–348 (2013).
   PubMed Web of Science ®Google Scholar
• Want EJ , WilsonID, GikaHet al. Global metabolic profiling procedures for urine using UPLC–MS. Nat. Protoc.5(6), 1005 (2010).
   PubMed Web of Science ®Google Scholar
• Vorkas PA , IsaacG, AnwarMAet al. Untargeted UPLC-MS profiling pipeline to expand tissue metabolome coverage: application to cardiovascular disease. Anal. Chem.87(8), 4184–4193 (2015).
   PubMed Web of Science ®Google Scholar
• Yu Z , KastenmüllerG, HeYet al. Differences between human plasma and serum metabolite profiles. PLoS ONE6(7), e21230 (2011).
   PubMed Web of Science ®Google Scholar
• Shen Z , KangP, RahavendranSV. Metabolite profiling of dasatinib dosed to Wistar Han rats using automated dried blood spot collection. J. Pharm. Biomed. Anal.67, 92–97 (2012).
   PubMed Web of Science ®Google Scholar
• Tretzel L , ThomasA, PiperTet al. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing. J. Pharm. Biomed. Anal.123, 132–140 (2016).
   PubMed Web of Science ®Google Scholar
• Varkhede NR , JhajraS, AhireDS, SinghS. Metabolite identification studies on amiodarone in in vitro (rat liver microsomes, rat and human liver S9 fractions) and in vivo (rat feces, urine, plasma) matrices by using liquid chromatography with high-resolution mass spectrometry and multiple-stage mass spectrometry: characterization of the diquinone metabolite supposedly responsible for the drug's hepatotoxicity. Rapid Commun. Mass Spectrom.28(4), 311–331 (2014).
   PubMed Web of Science ®Google Scholar
• Patel PN , KalariyaPD, SwamyCV, GananadhamuS, SrinivasR. Quantitation of acotiamide in rat plasma by UHPLC-Q-TOF-MS: method development, validation and application to pharmacokinetics. Biomed. Chromatogr.30(3), 363–368 (2016).
   PubMed Web of Science ®Google Scholar
• Chavan BB , KalariyaPD, TiwariSet al. Identification and characterization of vilazodone metabolites in rats and microsomes by ultrahigh-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry. Rapid Commun. Mass Spectrom.31(23), 1974–1984 (2017).
   PubMed Web of Science ®Google Scholar
• Attwa MW , KadiAA, AlrabiahH, DarwishHW. LC–MS/MS reveals the formation of iminium and quinone methide reactive intermediates in entrectinib metabolism: in vivo and in vitro metabolic investigation. J. Pharm. Biomed. Anal.160, 19–30 (2018).
   PubMed Web of Science ®Google Scholar
• Chavan BB , TiwariS, ShankarGet al. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites. J. Pharm. Biomed. Anal.157, 59–74 (2018).
   PubMed Web of Science ®Google Scholar
• Sun W , NguyenKD, FitchWLet al. In vitro and in vivo metabolite identification of a novel benzimidazole compound ZLN005 by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom.32(6), 480–488 (2018).
   PubMed Web of Science ®Google Scholar
• Stopfer P , MarzinK, NarjesHet al. Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers. Cancer Chemother. Pharmacol.69(4), 1051–1061 (2012).
   PubMed Web of Science ®Google Scholar
• Attwa MW , KadiAA, DarwishHW, AmerSM, Al-ShakliahNS. Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS. Chem. Cent. J.12(1), 1–16 (2018).
   PubMedGoogle Scholar
• Roosendaal J , RosingH, LucasLet al. Mass balance and metabolite profiling of 14 C-guadecitabine in patients with advanced cancer. Invest. New Drugs38(4), 1–11 (2019).
   PubMed Web of Science ®Google Scholar
• Shin S-H , ParkM-H, ByeonJ-Jet al. Analysis of vipadenant and its in vitro and in vivo metabolites via liquid chromatography-quadrupole-time-of-flight mass spectrometry. Pharmaceutics10(4), 260 (2018).
   PubMed Web of Science ®Google Scholar
• Thakkar D , KateAS. Update on metabolism of abemaciclib: in silico, in vitro, and in vivo metabolite identification and characterization using high resolution mass spectrometry. Drug test. Anal.12(3), 331–342 (2020).
   PubMed Web of Science ®Google Scholar
• Zhou L , LiuH, XuZ, GuanS, ZhangL. Identification and structural characterization of febuxostat metabolites in rat serum and urine samples using UHPLC–QTOF/MS. Biomed. Chromatogr.33(9), e4568 (2019).
   PubMed Web of Science ®Google Scholar
• Zhu C , WanM, ChengH, WangH, ZhuM, WuC. Rapid detection and structural characterization of verapamil metabolites in rats by UPLC–MSE and UNIFI platform. Biomed. Chromatogr.34(1), e4702 (2020).
   PubMed Web of Science ®Google Scholar
• Yang J , WangZ, FangYet al. Pharmacokinetics, pharmacodynamics, metabolism, distribution, and excretion of carfilzomib in rats. Drug Metab. Dispos.39(10), 1873–1882 (2011).
   PubMed Web of Science ®Google Scholar
• Yeole RD , RaneVP, AhirraoVKet al. Identification of metabolites of novel Anti-MRSA fluoroquinolone WCK 771 in mouse, rat, rabbit, dog, monkey and human urine using liquid chromatography tandem mass spectrometry. Biomed. Chromatogr.33(7), e4532 (2019).
   PubMed Web of Science ®Google Scholar
• Al-Shakliah NS , AttwaMW, KadiAA, AlrabiahH. Identification and characterization of in silico, in vivo, in vitro, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites. RSC Advances10(28), 16231–16244 (2020).
   PubMed Web of Science ®Google Scholar
• Tiwari SS , DhimanV, MukeshS, SangamwarAT, SrinivasR, TalluriMK. Identification and characterization of novel metabolites of nintedanib by ultra-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry with in silico toxicological assessment. Rapid Commun. Mass Spectrom.34(22), e8915 (2020).
   PubMed Web of Science ®Google Scholar
• Wang C , ZhangJ, ZhouSet al. Tentative identification of gefitinib metabolites in non-small-cell lung cancer patient plasma using ultra-performance liquid chromatography coupled with triple quadrupole time-of-flight mass spectrometry. PLoS ONE15(7), e0236523 (2020).
   PubMed Web of Science ®Google Scholar
• Wójtowicz M , JarekA, ChajewskaK, Turek-LepaE, KwiatkowskaD. Determination of designer doping agent–2-ethylamino-1-phenylbutane–in dietary supplements and excretion study following single oral supplement dose. J. Pharm. Biomed. Anal.115, 523–533 (2015).
   PubMed Web of Science ®Google Scholar
• Rzeppa S , VietL. Analysis of sulfate metabolites of the doping agents oxandrolone and danazol using high performance liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr. B.1029, 1–9 (2016).
   PubMed Web of Science ®Google Scholar
• Ameline A , GheddarL, RaulJ-S, KintzP. Characterization of letrozole in human hair using LC-MS/MS and confirmation by LC-HRMS: application to a doping case. J. Chromatogr. B.1162, 122495 (2021).
   PubMed Web of Science ®Google Scholar
• La Maida N , MannocchiG, GiorgettiR, SirignanoA, RicciG, BusardòFP. Optimization of a rapid sample pretreatment for the quantification of COCAINE and its main metabolites in hair through a new and validated GC-MS/MS method. J. Pharm. Biomed. Anal.204, 114282 (2021).
   PubMed Web of Science ®Google Scholar
• Ma S , ZengZ, LinMet al. PAHs and their hydroxylated metabolites in the human fingernails from e-waste dismantlers: implications for human non-invasive biomonitoring and exposure. Environ. Pollut.283, 117059 (2021).
   PubMed Web of Science ®Google Scholar
• Kim J , ChoH-D, SuhJHet al. Analysis of nicotine metabolites in hair and nails using QuEChERS method followed by liquid chromatography–tandem mass spectrometry. Molecules25(8), 1763 (2020).
   PubMed Web of Science ®Google Scholar
• Wishart DS . Advances in metabolite identification. Bioanalysis3(15), 1769–1782 (2011).
   PubMed Web of Science ®Google Scholar
• Gajula SNR , NanjappanS. Metabolomics: a recent advanced omics technology in herbal medicine research. In: Medicinal and Aromatic Plants. Elsevier, 97–117 (2021).
   Google Scholar
• Zhang H , ZhangD, RayK. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyzes. J. Mass Spectrom.38(10), 1110–1112 (2003).
   PubMed Web of Science ®Google Scholar
• Chen L-Z , JungnikA, MaoYet al. Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers. Xenobiotica45(6), 520–529 (2015).
   PubMed Web of Science ®Google Scholar
• Picó Y , BlascoC, FontG. Environmental and food applications of LC–tandem mass spectrometry in pesticide-residue analysis: an overview. Mass Spectrom. Rev.23(1), 45–85 (2004).
   PubMed Web of Science ®Google Scholar
• Soler C , MañesJ, PicóY. Comparison of liquid chromatography using triple quadrupole and quadrupole ion trap mass analyzers to determine pesticide residues in oranges. J. Chromatogr. A1067(1–2), 115–125 (2005).
   PubMed Web of Science ®Google Scholar
• Gautam N , LinZ, BanoubMGet al. Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC–MS/MS. J. Pharm. Biomed. Anal.153, 248–259 (2018).
   PubMed Web of Science ®Google Scholar
• Rashid MM , LeeH, JungBH. Metabolite identification and pharmacokinetic profiling of PP242, an ATP-competitive inhibitor of mTOR using ultra high-performance liquid chromatography and mass spectrometry. J. Chromatogr. B.1072, 244–251 (2018).
   PubMed Web of Science ®Google Scholar
• Rousu T , HerttuainenJ, TolonenA. Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time-of-flight and LTQ-Orbitrap mass spectrometers in drug discovery phase metabolite screening and identification in vitro–amitriptyline and verapamil as model compounds. Rapid Commun. Mass Spectrom.24(7), 939–957 (2010).
   PubMed Web of Science ®Google Scholar
• Hakala KS , KostiainenR, KetolaRA. Feasibility of different mass spectrometric techniques and programs for automated metabolite profiling of tramadol in human urine. Rapid Commun. Mass Spectrom.20(14), 2081–2090 (2006).
   PubMed Web of Science ®Google Scholar
• Tolonen A , TurpeinenM, PelkonenO. Liquid chromatography–mass spectrometry in in vitro drug metabolite screening. Drug Discov. Today14(3–4), 120–133 (2009).
   PubMed Web of Science ®Google Scholar
• Jemal M , OuyangZ, ZhaoW, ZhuM, WuWW. A strategy for metabolite identification using triple-quadrupole mass spectrometry with enhanced resolution and accurate mass capability. Rapid Commun. Mass Spectrom.17(24), 2732–2740 (2003).
   PubMed Web of Science ®Google Scholar
• Cotter RJ . Time-of-flight mass spectrometry. ACS Publications (1993).
   Google Scholar
• Wiley W , MclarenIH. Time-of-flight mass spectrometer with improved resolution. Rev. Sci. Instrum.26(12), 1150–1157 (1955).
   Web of Science ®Google Scholar
• Glish GL , GoeringerDE. A tandem quadrupole/time-of-flight instrument for mass spectrometry/mass spectrometry. Anal. Chem.56(13), 2291–2295 (1984).
   Web of Science ®Google Scholar
• El-Aneed A , CohenA, BanoubJ. Mass spectrometry, review of the basics: electrospray, MALDI, and commonly used mass analyzers. Appl. Spectrosc. Rev.44(3), 210–230 (2009).
   Web of Science ®Google Scholar
• Allen DR , McwhinneyBC. Quadrupole time-of-flight mass spectrometry: a paradigm shift in toxicology screening applications. Clin Biochem Rev40(3), 135 (2019).
   PubMedGoogle Scholar
• Kim J , BasiriB, HassanCet al. Metabolite profiling of the antisense oligonucleotide eluforsen using liquid chromatography-mass spectrometry. Mol. Ther. Nucleic Acids17, 714–725 (2019).
   PubMedGoogle Scholar
• Vishnuvardhan C , BaikadiS, BorkarRM, SrinivasR, SatheeshkumarN. In vivo metabolic investigation of silodosin using UHPLC–QTOF–MS/MS and in silico toxicological screening of its metabolites. J. Mass Spectrom.51(10), 867–882 (2016).
   PubMed Web of Science ®Google Scholar
• Li X , TangM, WangHet al. In Vitro and In Vivo Primary Metabolic Characterization of F18, a Novel Histone Deacetylase-6 (HDAC6) Inhibitor, Using UHPLC–QqQ–MS/MS and Q-TOF–MS Methods. Chromatographia79(21), 1479–1490 (2016).
   Web of Science ®Google Scholar
• Tian T , JinY, MaYet al. Identification of metabolites of oridonin in rats with a single run on UPLC-Triple-TOF-MS/MS system based on multiple mass defect filter data acquisition and multiple data processing techniques. J. Chromatogr. B.1006, 80–92 (2015).
   PubMed Web of Science ®Google Scholar
• Ludwig F-A , FischerS, SmitsRet al. Exploring the metabolism of (+)-[18f] flubatine in vitro and in vivo: lc-ms/ms aided identification of radiometabolites in a clinical pet study. Molecules23(2), 464 (2018).
   PubMed Web of Science ®Google Scholar
• Pan H , LiY, HuangL, ZhouX, LuY, ShiF. Development and validation of a rapid LC–MS/MS method for simultaneous quantification of arecoline and its two active metabolites in rat plasma and its application to a pharmacokinetic study. J. Pharm. Biomed. Anal.154, 397–403 (2018).
   PubMed Web of Science ®Google Scholar
• Dunn WB , BroadhurstD, BrownMet al. Metabolic profiling of serum using Ultra Performance Liquid Chromatography and the LTQ-Orbitrap mass spectrometry system. J. Chromatogr. B.871(2), 288–298 (2008).
   PubMed Web of Science ®Google Scholar
• Hu Q , NollRJ, LiH, MakarovA, HardmanM, GrahamCooks R. The Orbitrap: a new mass spectrometer. J. Mass Spectrom.40(4), 430–443 (2005).
   PubMed Web of Science ®Google Scholar
• Pelkonen O , TolonenA, KorjamoT, TurpeinenM, RaunioH. From known knowns to known unknowns: predicting in vivo drug metabolites. Bioanalysis1(2), 393–414 (2009).
   PubMed Web of Science ®Google Scholar
• Nassar A-EF , TalaatRE. Strategies for dealing with metabolite elucidation in drug discovery and development. Drug Discov. Today9(7), 317–327 (2004).
   PubMed Web of Science ®Google Scholar
• Viant MR , BeardenDW, BundyJGet al. International NMR-based environmental metabolomics intercomparison exercise. Environ. Sci. Technol.43(1), 219–225 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang S , GowdaGN, YeT, RafteryD. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst135(7), 1490–1498 (2010).
   PubMed Web of Science ®Google Scholar
• Ye T , MoH, ShanaiahN, GowdaGN, ZhangS, RafteryD. Chemoselective 15N tag for sensitive and high-resolution nuclear magnetic resonance profiling of the carboxyl-containing metabolome. Anal. Chem.81(12), 4882–4888 (2009).
   PubMed Web of Science ®Google Scholar
• Grimes JH , O'connellTM. The application of micro-coil NMR probe technology to metabolomics of urine and serum. J. Biomol. NMR49(3–4), 297–305 (2011).
   PubMed Web of Science ®Google Scholar
• Putzbach K , KruckerM, GrynbaumMD, HentschelP, WebbAG, AlbertK. Hyphenation of capillary high-performance liquid chromatography to microcoil magnetic resonance spectroscopy – determination of various carotenoids in a small-sized spinach sample. J. Pharm. Biomed. Anal.38(5), 910–917 (2005).
   PubMed Web of Science ®Google Scholar
• Polet M , Van EenooP. GC-C-IRMS in routine doping control practice: 3 years of drug testing data, quality control and evolution of the method. Anal. Bioanal. Chem.407(15), 4397–4409 (2015).
   PubMed Web of Science ®Google Scholar
• Looser R , KrotzkyAJ, TretheweyRN. Metabolite profiling with GC-MS and LC-MS. In: Metabolome analyzes: Strategies for Systems Biology.Springer, 103–118 (2005).
   Google Scholar
• Zeki ÖC , EylemCC, ReçberT, KırS, NemutluE. Integration of GC-MS and LC-MS for untargeted metabolomics profiling. J. Pharm. Biomed. Anal.113509 (2020).
   Google Scholar
• Kopka J . Current challenges and developments in GC–MS based metabolite profiling technology. J. Biotechnol.124(1), 312–322 (2006).
   PubMed Web of Science ®Google Scholar
• Savchuk S , AppolonovaS, PechnikovA, RizvanovaL, ShestakovaK, TagliaroF. In vivo metabolism of the new synthetic cannabinoid APINAC in rats by GC–MS and LC–QTOF-MS. Forensic Toxicol.35(2), 359–368 (2017).
   Web of Science ®Google Scholar
• Ooms JA , KnegtL, KosterEHM. Exploration of a new concept for automated dried blood spot analysis using flow-through desorption and online SPE–MS/MS. Bioanalysis3(20), 2311–2320 (2011).
   PubMed Web of Science ®Google Scholar
• Hu B , ZhengB, RickertDet al. Direct coupling of solid phase microextraction with electrospray ionization mass spectrometry: a case study for detection of ketamine in urine. Anal. Chim. Acta1075, 112–119 (2019).
   PubMed Web of Science ®Google Scholar
• Ng TT . Rapid determination of drugs-of-abuse in urine and oral fluid and rapid authentication of edible oils by mass spectrometry (2018). https://theses.lib.polyu.edu.hk/handle/200/9596
   Google Scholar
• Zhu M , MaL, ZhangDet al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab. Dispos.34(10), 1722–1733 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang H , ZhangD, RayK, ZhuM. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. J. Mass Spectrom.44(7), 999–1016 (2009).
   PubMed Web of Science ®Google Scholar
• Sleno L . The use of mass defect in modern mass spectrometry. J. Mass Spectrom.47(2), 226–236 (2012).
   PubMed Web of Science ®Google Scholar
• Déglon J , ThomasA, DaaliYet al. Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite. J. Pharm. Biomed. Anal.54(2), 359–367 (2011).
   PubMed Web of Science ®Google Scholar
• Guthrie R . Blood screening for phenylketonuria. JAMA178(8), 863–863 (1961).
   Web of Science ®Google Scholar
• Mcdade TW , WilliamsS, SnodgrassJJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography44(4), 899–925 (2007).
   PubMed Web of Science ®Google Scholar
• Vu D , KosterR, BolhuisMet al. Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS. Talanta121, 9–17 (2014).
   PubMed Web of Science ®Google Scholar
• Sonti R , Hertel-HeringI, LamontanaraAJ, HantschelO, GrzesiekS. ATP site ligands determine the assembly state of the Abelson kinase regulatory core via the activation loop conformation. J. Am. Chem. Soc.140(5), 1863–1869 (2018).
   PubMed Web of Science ®Google Scholar
• Hantschel O , GrebienF, Superti-FurgaG. The growing arsenal of ATP-competitive and allosteric inhibitors of BCR–ABL. Cancer Res.72(19), 4890–4895 (2012).
   PubMed Web of Science ®Google Scholar
• Fiehn O , KindT. Metabolite profiling in blood plasma. In: Metabolomics, Springer ( Eds). 3–17 (2007).
   Google Scholar
• Kulkarni P , KaranamA, GurjarMet al. Effect of various anticoagulants on the bioanalysis of drugs in rat blood: implication for pharmacokinetic studies of anticancer drugs. Springerplus5(1), 1–8 (2016).
   PubMedGoogle Scholar
• Skov K , HadrupN, SmedsgaardJ, FrandsenH. LC–MS analysis of the plasma metabolome—A novel sample preparation strategy. J. Chromatogr. B.978, 83–88 (2015).
   PubMed Web of Science ®Google Scholar
• Psychogios N , HauDD, PengJet al. The human serum metabolome. PLoS ONE6(2), e16957 (2011).
   PubMed Web of Science ®Google Scholar
• Josefsson M , SabanovicA. Sample preparation on polymeric solid phase extraction sorbents for liquid chromatographic-tandem mass spectrometric analysis of human whole blood—A study on a number of beta-agonists and beta-antagonists. J. Chromatogr. A1120(1–2), 1–12 (2006).
   PubMed Web of Science ®Google Scholar
• Deda O , GikaHG, WilsonID, TheodoridisGA. An overview of fecal sample preparation for global metabolic profiling. J. Pharm. Biomed. Anal.113, 137–150 (2015).
   PubMed Web of Science ®Google Scholar
• Cao H , HuangH, XuWet al. Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography–mass spectrometry. Anal. Chim. Acta691(1–2), 68–75 (2011).
   PubMed Web of Science ®Google Scholar
• Kalariya PD , PatelPN, KavyaPet al. Rapid structural characterization of in vivo and in vitro metabolites of tinoridine using UHPLC–QTOF–MS/MS and in silico toxicological screening of its metabolites. J. Mass Spectrom.50(11), 1222–1233 (2015).
   PubMed Web of Science ®Google Scholar
• Shankar G , BorkarRM, UduthaS, AnagoniSP, SrinivasR. Identification and structural characterization of in vivo metabolites of balofloxacin in rat plasma, urine and feces samples using Q-TOF/LC/ESI/MS/MS: in silico toxicity studies. J. Pharm. Biomed. Anal.159, 200–211 (2018).
   PubMed Web of Science ®Google Scholar
• Linton A , HedgesA, BennettP. Monitoring for the development of antimicrobial resistance during the use of olaquindox as a feed additive on commercial pig farms. J. Appl. Bacteriol.64(4), 311–327 (1988).
   PubMedGoogle Scholar
• Bi Y , WangX, XuSet al. Metabolism of olaquindox in rat and identification of metabolites in urine and feces using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom.25(7), 889–898 (2011).
   PubMed Web of Science ®Google Scholar
• Chavan BB , KalariyaPD, NimbalkarRD, GargP, SrinivasR, KumarTalluri M. Identification and characterization of fluvastatin metabolites in rats by UHPLC/Q-TOF/MS/MS and in silico toxicological screening of the metabolites. J. Mass Spectrom.52(5), 296–314 (2017).
   PubMed Web of Science ®Google Scholar
• Wohlfarth A , ScheidweilerKB, ChenX, LiuH-F, HuestisMA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC–MS/MS and library search. Anal. Chem.85(7), 3730–3738 (2013).
   PubMed Web of Science ®Google Scholar
• Wissenbach DK . Development of the first metabolite-based LC-MSn urine drug screening procedure. 400(1), 79–88 (2012).
   Google Scholar
• Zhou G , ShiS, ZhangWet al. Identification of ilaprazole metabolites in human urine by HPLC-ESI-MS/MS and HPLC-NMR experiments. Biomed. Chromatogr.24(10), 1130–1135 (2010).
   PubMed Web of Science ®Google Scholar
• Csajka C , MarzoliniC, FattingerKet al. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection. Clin. Pharmacol. Ther.73(1), 20–30 (2003).
   PubMed Web of Science ®Google Scholar
• Aouri M , BarceloC, TernonBet al. In vivo profiling and distribution of known and novel phase I and phase II metabolites of efavirenz in plasma, urine, and cerebrospinal fluid. Drug Metab. Dispos.44(1), 151–161 (2016).
   PubMed Web of Science ®Google Scholar
• Lu J , HeG, WangXet al. Mass spectrometric identification and characterization of new clomiphene metabolites in human urine by liquid chromatography–quadrupole time-of-flight tandem mass spectrometry. J. Chromatogr. A1243, 23–32 (2012).
   PubMed Web of Science ®Google Scholar
• Morita S , OtsuboK, UchidaM, KawabataS, TamaokaH, ShimizuT. Synthesis and antibacterial activity of the metabolites of 9-fluoro-6, 7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H, 5H-benzo [i, j] quinolizine-2-carboxylic acid (OPC-7251). Chem. Pharm. Bull. (Tokyo)38(7), 2027–2029 (1990).
   PubMed Web of Science ®Google Scholar
• Thevis M , PiperT, ThomasA. Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing. J. Pharm. Biomed. Anal.205, 114312 (2021).
   PubMed Web of Science ®Google Scholar
• De Jager AD , WarnerJV, HenmanM, FergusonW, HallA. LC–MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine – an Australian perspective. J. Chromatogr. B.897, 22–31 (2012).
   PubMed Web of Science ®Google Scholar
• Basomba A , PelaezA, VillalmanzoI, CamposA. Allergy to penicillin unsuccessfully treated with a haptenic inhibitor (benzyl-penicilloyl-N2-formil-lysine; BPO-Flys): a case report. Clin. Exp. Allergy8(4), 341–345 (1978).
   Google Scholar
• Ho HP , LeeRJ, ChenCY, WangSR, LiZG, LeeMR. Identification of new minor metabolites of penicillin G in human serum by multiple-stage tandem mass spectrometry. Rapid Commun. Mass Spectrom.25(1), 25–32 (2011).
   PubMed Web of Science ®Google Scholar
• Frampton JE . Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout. Drugs75(4), 427–438 (2015).
   PubMed Web of Science ®Google Scholar
• Schumacher H Jr , BeckerM, LloydE, MacdonaldP, LademacherC. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology (Oxford)48(2), 188–194 (2009).
   PubMed Web of Science ®Google Scholar
• Edwards NL . Febuxostat: a new treatment for hyperuricaemia in gout. Rheumatology (Oxford)48(Suppl. 2), ii15–ii19 (2009).
   PubMed Web of Science ®Google Scholar
• Vincenti M , SalomoneA, GeraceE, PirroV. Application of mass spectrometry to hair analysis for forensic toxicological investigations. Mass Spectrom. Rev.32(4), 312–332 (2013).
   PubMed Web of Science ®Google Scholar
• Pragst F , BalikovaMA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin. Chim. Acta370(1–2), 17–49 (2006).
   PubMed Web of Science ®Google Scholar
• Koster RA , AlffenaarJ-WC, GreijdanusB, VandernagelJE, UgesDR. Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse. Ther. Drug Monit.36(2), 234–243 (2014).
   PubMed Web of Science ®Google Scholar
• Musshoff F , MadeaB. Analytical pitfalls in hair testing. Anal. Bioanal. Chem.388(7), 1475–1494 (2007).
   PubMed Web of Science ®Google Scholar
• Cappelle D , YeglesM, NeelsHet al. Nail analysis for the detection of drugs of abuse and pharmaceuticals: a review. Forensic Toxicol.33(1), 12–36 (2015).
   Web of Science ®Google Scholar
• Cappelle D , DeDoncker M, GysCet al. A straightforward, validated liquid chromatography coupled to tandem mass spectrometry method for the simultaneous detection of nine drugs of abuse and their metabolites in hair and nails. Anal. Chim. Acta960, 101–109 (2017).
   PubMed Web of Science ®Google Scholar
• Magalhães TP , CravoS, SilvaDDDet al. Quantification of methadone and main metabolites in nails. J. Anal. Toxicol.42(3), 192–206 (2018).
   PubMed Web of Science ®Google Scholar
• Cobo-Golpe M , De-Castro-RíosA, CruzA, López-RivadullaM, LendoiroE. Determination and distribution of cannabinoids in nail and hair samples. J. Anal. Toxicol. (2020).
   Google Scholar
• Ginsburg BC , SchulzeDR, HrubaL, McmahonLR. JWH-018 and JWH-073: Δ9-tetrahydrocannabinol-like discriminative stimulus effects in monkeys. J. Pharmacol. Exp. Ther.340(1), 37–45 (2012).
   PubMed Web of Science ®Google Scholar
• Chung H , ChoiH, HeoS, KimE, LeeJ. Synthetic cannabinoids abused in South Korea: drug identifications by the National Forensic Service from 2009 to June 2013. Forensic Toxicol.32(1), 82–88 (2014).
   Web of Science ®Google Scholar
• Kim J , InS, ParkY, ParkM, KimE, LeeS. Deposition of JWH-018, JWH-073 and their metabolites in hair and effect of hair pigmentation. Anal. Bioanal. Chem.405(30), 9769–9778 (2013).
   PubMed Web of Science ®Google Scholar
• Park M , YeonS, LeeJ, InS. Determination of XLR-11 and its metabolites in hair by liquid chromatography–tandem mass spectrometry. J. Pharm. Biomed. Anal.114, 184–189 (2015).
   PubMed Web of Science ®Google Scholar